July 20, 2018

July 20, 2018

Subscribe to Latest Legal News and Analysis

July 19, 2018

Subscribe to Latest Legal News and Analysis

July 18, 2018

Subscribe to Latest Legal News and Analysis

Congress Takes on Opioid Epidemic, Aims to Provide Tools for Public Health

In a recently released Center for Disease Control (CDC) report entitled “Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants – United States, 2015-2016,” trends in what has become known as the “opioid epidemic” were reviewed. The data is based on statistics gathered from 1999-2015 and relies on information contained in the National Vital Statistics System. In total, 568,699 people died between 1999 and 2015 from drug overdoses in the United States. A total of 63,632 people died in 2016 and, of this number, 42,249 deaths involved an opioid. Increases in mortality rates were noted across all demographics, urbanization levels, and states. This represents a 27.9% increase in overdose mortality figures from 2015.

In a report by the American Action Forum, the opioid crisis is thought to have cost the United States as much as $700 billion and removed 919,400 prime-age workers from the labor market (2015). This has resulted in an estimated loss of 12.1 billion work hours from 1999-2015.

The CDC has urged that efforts to reverse this disturbing trend be multifaceted, with improved surveillance of usage, increased naloxone availability, improved safe-prescribing practices, better linkage to treatment options, and increased collaboration between health and public safety agencies.

To that end, the House Energy and Commerce Committee has held hearings on various issues related to the opioid epidemic throughout 2017 and 2018. In addition, several bills have been introduced, including H.R. 2851, the “Stop Importation and Trafficking of Synthetic Analogues Act” authored by Rep. John Katko (R-New York), which provides law enforcement some additional tools to combat synthetic drugs. Two other bills are a discussion draft that would provide grants to help establish public health laboratories introduced by Rep. Ann Kuster, D-New Hampshire, and H.R. 449, the “Synthetic Drug Awareness Act, introduced by Rep. Hakeem Jeffries (D-New York) requiring the Surgeon General to prepare a comprehensive report to Congress on synthetic drug use among youth.

© 2018 BARNES & THORNBURG LLP

TRENDING LEGAL ANALYSIS


About this Author

Ronnie Miller, Barnes Thornburg, litigation attorney
Of Counsel

Ronnie L. Miller is of counsel in the Washington, D.C., and Indianapolis offices of Barnes & Thornburg. A member of the firm’s Government Services and Finance Department, Mr. Miller serves as federal compliance counsel for government services and is also involved with professional responsibility and various legal ethics and conflict matters. He is involved in political law issues and advises clients on election and campaign laws, political action committees, and lobbying activities. Additionally, Mr. Miller is also a member of the Litigation and Labor and Employment...

202-408-6923

Barnes & Thornburg LLP features a full-service government relations team. The Washington-based Federal Relations Group offers firm clients lobbying and regulatory representation before Members of Congress and their staffs, administration officials, regulatory decision-makers, and committee and leadership staff on Capitol Hill. The Federal Relations Group, which involves lawyers and lobbyists from all Barnes & Thornburg practice areas, also offers strategic advice, coalition building, political, policy, and communications advice to assist clients with federal government interactions.

The Federal Relations Group is bipartisan. Our lobbyists have advised governors, senators, and congressmen from both political parties on policy and political matters. With that background, the Federal Relations Group can offer clients insights as to how the federal government operates and, as importantly, what committees, departments, and people are key to the client’s issues before the federal government.

202-408-6903